Trials / Unknown
UnknownNCT00924079
The Development of Oral Nalbuphine Dosage Form
Pharmacokinetic Study of Oral Nalbuphine in Normal Healthy Subjects
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tri-Service General Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate possible responses to pharmacokinetic properties for nalbuphine oral formulations in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nalbuphine | oral dosage form, 66 mg, single dose |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-11-01
- First posted
- 2009-06-18
- Last updated
- 2009-06-19
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00924079. Inclusion in this directory is not an endorsement.